Hatteras’ mission is to build transformational human medicine companies that benefit patients and the professionals who serve them. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.


Latest News

Sir Andrew Witty Joins Hatteras Venture Partners

September 19, 2017

Former CEO of GlaxoSmithKline to focus on strategic positioning of Hatteras and its portfolio companies as a Venture Partner Sept. 19, 2017 — DURHAM, NC — Hatteras Venture Partners today…

More News